Deciphering the multidimensional impact of IGFBP1 expression on cancer prognosis, genetic alterations, and cellular functionality: A comprehensive Pan-cancer analysis
These findings highlight IGFBP1's potential as a biomarker and therapeutic target, particularly for immunoregulation and cancer subtype stratification.
Authors
- Lixin Jiang (ORCID: https://orcid.org/0000-0002-8782-5616)
- Ruyue Chen (ORCID: https://orcid.org/0000-0002-0847-4740)
- Zengwu Yao
- Xixun Wang
- Jinhui Wu (ORCID: https://orcid.org/0000-0001-8809-1290)
- Jinchen Hu (ORCID: https://orcid.org/0000-0002-2674-0782)
- Mi Jian (ORCID: https://orcid.org/0000-0001-8851-0811)
- Yifei Zhang (ORCID: https://orcid.org/0000-0001-5961-9180)
- Miaomiao Li (ORCID: https://orcid.org/0000-0003-2481-0326)
- Junping Han
- Zhensong Yang (ORCID: https://orcid.org/0009-0005-6794-3585)
Institutions
- Qingdao University (CN)
- Shandong University (CN)
- Yuhuangding Hospital (CN)
- Yantaishan Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37402
- Citations
- 4
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.14